PHVS Stock Analysis: Buy, Sell, or Hold?
PHVS - Pharvaris N.V. Ordinary Shares
$33.19
0.19 (0.58%)
▲
5d:
+5.23%
30d:
+8.68%
90d:
+29.14%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When PHVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PHVS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: PHVS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PHVS is currently trading at $33.19, which is considered extended relative to its 30-day fair value range of $29.45 to $32.17.
Technical Outlook: Technically, PHVS is in a strong uptrend. Immediate support is located at $30.27, while resistance sits at $34.41.
Market Sentiment: PHVS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (8th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $45.64 (+37.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHVS is in a strong uptrend. Immediate support is located at $30.27, while resistance sits at $34.41.
Market Sentiment: PHVS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (8th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $45.64 (+37.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.45 -
$32.17
Company Quality Score
67/100
(BUY)
Options IV Signal
8th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 8th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.5% below Wall St target ($45.64)
Trading Range Analysis
30-Day Trading Range
$29.45 -
$32.17
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$5.61
(16.9%)
Support & Resistance Levels
Support Level
$30.27
Resistance Level
$34.41
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.32
Wall Street Target
$45.64
(+37.5%)
Share & Embed Analysis
Last updated: June 23, 2026 5:25 PM ET
Data refreshes hourly during market hours. Next update: 6:25 PM
Data refreshes hourly during market hours. Next update: 6:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Anne Lesage
SELL
100 shares
2026-04-23
Johannes Gerardus Chri S…
SELL
100 shares
2026-04-23
Peng Lu
SELL
100 shares
2026-04-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
Advanced PHVS Option Strategies
Professional options setups generated by AI based on today's PHVS price and gamma walls.
